CIHR

The Can-Share program seeks to build policies and data tools to share data among Canadian research institutions and with international partners.

NEW YORK (GenomeWeb News) – Canada has launched a C$41 million (US$41.2 million) initiative to fund epigenetics research programs through collaborations between the Canadian Institute of Health Research (CIHR), Genome Quebec and Genome BC, the government of Japan, and the Fonds de Recherche Sante

"A key ethical question is, when you do this next-gen whole-genome sequencing, do you return that information back to the families and patients? A part of this project is to study that question," said Poul Sorensen of the BC Cancer Agency.

The C$4 million, year-long project will utilize primarily exome sequencing, and will likely focus on rare Mendelian diseases and pediatric cancers, according to officials at the Canadian Institute of Health Research and Genome Canada.

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.